Encompass Health (NYSE: EHC) is scheduled to reveal its financial results for the second quarter on Monday 5th August 2024. This disclosure will take place after market close, providing investors with significant information regarding the company’s performance in the last three months period.
Financial experts on Wall Street anticipate that the concern is set to announce an estimated $1.01 profit per share for the quarter. Furthermore, the company is expected to disclose a total revenue of $1.3 billion for this specific period.
Rolling out their 2024 plans, EHC has predicted a revenue ranging from $5.25 to $5.33 billion, with an anticipation of earnings around $3.86 to $4.11 profit per share, At the same time the wall street analysts expect that the bottom line will be at profit of $4.11 per share supported by revenues of $5.31 billion.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Q1 2024 | $1.12 | +27.3% | 1.32 B | +13.4% |
| Q4 2023 | $0.95 | +8.0% | 1.25 B | +9.7% |
| Q3 2023 | $0.86 | +28.4% | 1.21 B | +10.7% |
| Q2 2023 | $0.95 | +6.7% | 1.19 B | -10.8% |
*Growth on year-over-year basis
During the same quarter of the previous year, the company made public its income of $0.95 per share, which were derived from a quarterly revenue of $1187 million.EHC has scheduled a conference call on 6th August 2024 at 10:00 AM eastern time to discuss the second quarter financial results and other related information.
Throughout the trading day, Encompass Health (EHC) shares fluctuated between $91.32 and $93.02, with a trading volume of 774.20 thousand shares. The stock ended the regular trading session at $92.71, marking decrease of 0.33 percent.